BMRN Return on Tangible Equity | BIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC (BMRN) Return on Tangible Equity

2026-06-30: Return Tang Equity 9.28%.
2026-03-31: Return Tang Equity 4.62%.
2025-12-31: Return Tang Equity 6.15%.
2025-09-30: Return Tang Equity 9.25%.

Complete source-backed return tang equity history.

Available history: 2008-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	9.28%
2026-03-31	4.62%
2025-12-31	6.15%
2025-09-30	9.25%
2025-06-30	11.75%
2025-03-31	9.79%
2024-12-31	8.20%
2024-09-30	6.50%
2024-06-30	5.32%
2024-03-31	4.47%
2023-12-31	3.76%
2023-09-30	3.34%
2023-06-30	2.34%
2023-03-31	1.73%
2022-12-31	3.48%
2022-09-30	2.11%
2022-06-30	1.38%
2022-03-31	1.04%
2021-12-31	-1.74%
2021-09-30	0.30%
2021-06-30	22.97%
2021-03-31	22.26%
2020-12-31	24.49%
2020-09-30	25.05%
2020-06-30	4.73%
2020-03-31	4.41%
2019-12-31	-0.97%
2019-09-30	-1.48%
2019-06-30	-3.99%
2019-03-31	-3.71%
2018-12-31	-2.96%
2018-09-30	-5.22%
2018-06-30	-5.29%
2018-03-31	-6.34%
2017-12-31	-4.84%
2017-09-30	-6.85%
2017-06-30	-8.00%
2017-03-31	-25.16%
2016-12-31	-26.84%
2016-09-30	-22.25%
2016-06-30	-37.77%
2016-03-31	-16.18%
2015-12-31	-8.08%
2015-09-30	-24.27%
2015-06-30	-16.20%
2015-03-31	-11.87%
2014-12-31	-9.63%
2014-09-30	-9.14%
2014-06-30	-14.00%
2014-03-31	-13.12%
2013-12-31	-14.55%
2013-09-30	-14.58%
2013-06-30	-10.60%
2013-03-31	-11.63%
2012-12-31	-12.70%
2012-09-30	-9.79%
2012-06-30	-11.34%
2012-03-31	-11.30%
2011-12-31	-8.27%
2011-09-30	-5.43%
2011-06-30	28.81%
2011-03-31	29.99%
2010-12-31	31.00%
2010-09-30	41.84%
2010-06-30	3.73%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	6.15%
2024-12-31	8.20%
2023-12-31	3.76%
2022-12-31	3.48%
2021-12-31	-1.74%
2020-12-31	24.49%
2019-12-31	-0.97%
2018-12-31	-2.96%
2017-12-31	-4.84%
2016-12-31	-26.84%
2015-12-31	-8.08%
2014-12-31	-9.63%
2013-12-31	-14.55%
2012-12-31	-12.70%
2011-12-31	-8.27%
2010-12-31	31.00%
2009-12-31	-0.16%
2008-12-31	11.14%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05